Cephalon To Pay $425M To End Federal Investigation

Law360, New York (November 9, 2007, 12:00 AM EST) -- Drugmaker Cephalon Inc. has agreed to pay $425 million to settle an investigation into the company's sales and marketing practices by the Philadelphia U.S. Attorney's office and the U.S. Department of Justice, the company revealed Thursday.

As part of the settlement, Cephalon said it would also accept a single misdemeanor violation of the U.S. Food, Drug and Cosmetic Act. The deal puts to rest federal and related state Medicaid claims, according to Cephalon. The Frazer, Penn.- based pharmaceutical company also said it intends to sign a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.